The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Research Report 2025
Synopsis
Des-gamma-carboxy prothrombin (DCP) is an abnormal form of prothrombin, a clotting factor produced by the liver. This test measures the amount of DCP in the blood to help evaluate whether treatment for one type of liver cancer, hepatocellular carcinoma (HCC), is effective.
The global Des-γ-carboxy Prothrombin (DCP) Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Des-γ-carboxy Prothrombin (DCP) Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Des-γ-carboxy Prothrombin (DCP) Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Des-γ-carboxy Prothrombin (DCP) Biomarker in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Des-γ-carboxy Prothrombin (DCP) Biomarker include FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp and Thermo Fisher Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Des-γ-carboxy Prothrombin (DCP) Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Des-γ-carboxy Prothrombin (DCP) Biomarker.
Report Scope
The Des-γ-carboxy Prothrombin (DCP) Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Des-γ-carboxy Prothrombin (DCP) Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Des-γ-carboxy Prothrombin (DCP) Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
FUJIFILM
Eli Lilly and Company
Fujirebio
Roche Diagnostics
Fapon Biotech
Labcorp
Thermo Fisher Scientific
Segment by Type
Hepatocellular Carcinoma
Anticoagulant Intoxication
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Des-γ-carboxy Prothrombin (DCP) Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Des-gamma-carboxy prothrombin (DCP) is an abnormal form of prothrombin, a clotting factor produced by the liver. This test measures the amount of DCP in the blood to help evaluate whether treatment for one type of liver cancer, hepatocellular carcinoma (HCC), is effective.
The global Des-γ-carboxy Prothrombin (DCP) Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Des-γ-carboxy Prothrombin (DCP) Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Des-γ-carboxy Prothrombin (DCP) Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Des-γ-carboxy Prothrombin (DCP) Biomarker in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Des-γ-carboxy Prothrombin (DCP) Biomarker include FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp and Thermo Fisher Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Des-γ-carboxy Prothrombin (DCP) Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Des-γ-carboxy Prothrombin (DCP) Biomarker.
Report Scope
The Des-γ-carboxy Prothrombin (DCP) Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Des-γ-carboxy Prothrombin (DCP) Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Des-γ-carboxy Prothrombin (DCP) Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
FUJIFILM
Eli Lilly and Company
Fujirebio
Roche Diagnostics
Fapon Biotech
Labcorp
Thermo Fisher Scientific
Segment by Type
Hepatocellular Carcinoma
Anticoagulant Intoxication
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Des-γ-carboxy Prothrombin (DCP) Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hepatocellular Carcinoma
1.2.3 Anticoagulant Intoxication
1.2.4 Others
1.3 Market by Application
1.3.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Perspective (2019-2030)
2.2 Des-γ-carboxy Prothrombin (DCP) Biomarker Growth Trends by Region
2.2.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Des-γ-carboxy Prothrombin (DCP) Biomarker Historic Market Size by Region (2019-2024)
2.2.3 Des-γ-carboxy Prothrombin (DCP) Biomarker Forecasted Market Size by Region (2025-2030)
2.3 Des-γ-carboxy Prothrombin (DCP) Biomarker Market Dynamics
2.3.1 Des-γ-carboxy Prothrombin (DCP) Biomarker Industry Trends
2.3.2 Des-γ-carboxy Prothrombin (DCP) Biomarker Market Drivers
2.3.3 Des-γ-carboxy Prothrombin (DCP) Biomarker Market Challenges
2.3.4 Des-γ-carboxy Prothrombin (DCP) Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Des-γ-carboxy Prothrombin (DCP) Biomarker Players by Revenue
3.1.1 Global Top Des-γ-carboxy Prothrombin (DCP) Biomarker Players by Revenue (2019-2024)
3.1.2 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue
3.4 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Concentration Ratio
3.4.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue in 2023
3.5 Des-γ-carboxy Prothrombin (DCP) Biomarker Key Players Head office and Area Served
3.6 Key Players Des-γ-carboxy Prothrombin (DCP) Biomarker Product Solution and Service
3.7 Date of Enter into Des-γ-carboxy Prothrombin (DCP) Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Des-γ-carboxy Prothrombin (DCP) Biomarker Breakdown Data by Type
4.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Historic Market Size by Type (2019-2024)
4.2 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Forecasted Market Size by Type (2025-2030)
5 Des-γ-carboxy Prothrombin (DCP) Biomarker Breakdown Data by Application
5.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Historic Market Size by Application (2019-2024)
5.2 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size (2019-2030)
6.2 North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2019-2024)
6.4 North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size (2019-2030)
7.2 Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2019-2024)
7.4 Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size (2019-2030)
8.2 Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region (2019-2024)
8.4 Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size (2019-2030)
9.2 Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2019-2024)
9.4 Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size (2019-2030)
10.2 Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2019-2024)
10.4 Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FUJIFILM
11.1.1 FUJIFILM Company Detail
11.1.2 FUJIFILM Business Overview
11.1.3 FUJIFILM Des-γ-carboxy Prothrombin (DCP) Biomarker Introduction
11.1.4 FUJIFILM Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024)
11.1.5 FUJIFILM Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Detail
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Des-γ-carboxy Prothrombin (DCP) Biomarker Introduction
11.2.4 Eli Lilly and Company Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024)
11.2.5 Eli Lilly and Company Recent Development
11.3 Fujirebio
11.3.1 Fujirebio Company Detail
11.3.2 Fujirebio Business Overview
11.3.3 Fujirebio Des-γ-carboxy Prothrombin (DCP) Biomarker Introduction
11.3.4 Fujirebio Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024)
11.3.5 Fujirebio Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Detail
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics Des-γ-carboxy Prothrombin (DCP) Biomarker Introduction
11.4.4 Roche Diagnostics Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024)
11.4.5 Roche Diagnostics Recent Development
11.5 Fapon Biotech
11.5.1 Fapon Biotech Company Detail
11.5.2 Fapon Biotech Business Overview
11.5.3 Fapon Biotech Des-γ-carboxy Prothrombin (DCP) Biomarker Introduction
11.5.4 Fapon Biotech Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024)
11.5.5 Fapon Biotech Recent Development
11.6 Labcorp
11.6.1 Labcorp Company Detail
11.6.2 Labcorp Business Overview
11.6.3 Labcorp Des-γ-carboxy Prothrombin (DCP) Biomarker Introduction
11.6.4 Labcorp Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024)
11.6.5 Labcorp Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Detail
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Des-γ-carboxy Prothrombin (DCP) Biomarker Introduction
11.7.4 Thermo Fisher Scientific Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024)
11.7.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hepatocellular Carcinoma
Table 3. Key Players of Anticoagulant Intoxication
Table 4. Key Players of Others
Table 5. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Region (2019-2024)
Table 9. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Region (2025-2030)
Table 11. Des-γ-carboxy Prothrombin (DCP) Biomarker Market Trends
Table 12. Des-γ-carboxy Prothrombin (DCP) Biomarker Market Drivers
Table 13. Des-γ-carboxy Prothrombin (DCP) Biomarker Market Challenges
Table 14. Des-γ-carboxy Prothrombin (DCP) Biomarker Market Restraints
Table 15. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Players (2019-2024)
Table 17. Global Top Des-γ-carboxy Prothrombin (DCP) Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker as of 2023)
Table 18. Ranking of Global Top Des-γ-carboxy Prothrombin (DCP) Biomarker Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Des-γ-carboxy Prothrombin (DCP) Biomarker Product Solution and Service
Table 22. Date of Enter into Des-γ-carboxy Prothrombin (DCP) Biomarker Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue Market Share by Type (2019-2024)
Table 26. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue Market Share by Type (2025-2030)
Table 28. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue Market Share by Application (2019-2024)
Table 30. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue Market Share by Application (2025-2030)
Table 32. North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 47. FUJIFILM Company Detail
Table 48. FUJIFILM Business Overview
Table 49. FUJIFILM Des-γ-carboxy Prothrombin (DCP) Biomarker Product
Table 50. FUJIFILM Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024) & (US$ Million)
Table 51. FUJIFILM Recent Development
Table 52. Eli Lilly and Company Company Detail
Table 53. Eli Lilly and Company Business Overview
Table 54. Eli Lilly and Company Des-γ-carboxy Prothrombin (DCP) Biomarker Product
Table 55. Eli Lilly and Company Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024) & (US$ Million)
Table 56. Eli Lilly and Company Recent Development
Table 57. Fujirebio Company Detail
Table 58. Fujirebio Business Overview
Table 59. Fujirebio Des-γ-carboxy Prothrombin (DCP) Biomarker Product
Table 60. Fujirebio Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024) & (US$ Million)
Table 61. Fujirebio Recent Development
Table 62. Roche Diagnostics Company Detail
Table 63. Roche Diagnostics Business Overview
Table 64. Roche Diagnostics Des-γ-carboxy Prothrombin (DCP) Biomarker Product
Table 65. Roche Diagnostics Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024) & (US$ Million)
Table 66. Roche Diagnostics Recent Development
Table 67. Fapon Biotech Company Detail
Table 68. Fapon Biotech Business Overview
Table 69. Fapon Biotech Des-γ-carboxy Prothrombin (DCP) Biomarker Product
Table 70. Fapon Biotech Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024) & (US$ Million)
Table 71. Fapon Biotech Recent Development
Table 72. Labcorp Company Detail
Table 73. Labcorp Business Overview
Table 74. Labcorp Des-γ-carboxy Prothrombin (DCP) Biomarker Product
Table 75. Labcorp Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024) & (US$ Million)
Table 76. Labcorp Recent Development
Table 77. Thermo Fisher Scientific Company Detail
Table 78. Thermo Fisher Scientific Business Overview
Table 79. Thermo Fisher Scientific Des-γ-carboxy Prothrombin (DCP) Biomarker Product
Table 80. Thermo Fisher Scientific Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024) & (US$ Million)
Table 81. Thermo Fisher Scientific Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Type: 2023 VS 2030
Figure 3. Hepatocellular Carcinoma Features
Figure 4. Anticoagulant Intoxication Features
Figure 5. Others Features
Figure 6. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Des-γ-carboxy Prothrombin (DCP) Biomarker Report Years Considered
Figure 12. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Region: 2023 VS 2030
Figure 15. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Players in 2023
Figure 16. Global Top Des-γ-carboxy Prothrombin (DCP) Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue in 2023
Figure 18. North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Country (2019-2030)
Figure 20. United States Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Country (2019-2030)
Figure 24. Germany Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Region (2019-2030)
Figure 32. China Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Country (2019-2030)
Figure 40. Mexico Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Country (2019-2030)
Figure 44. Turkey Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. FUJIFILM Revenue Growth Rate in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024)
Figure 47. Eli Lilly and Company Revenue Growth Rate in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024)
Figure 48. Fujirebio Revenue Growth Rate in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024)
Figure 49. Roche Diagnostics Revenue Growth Rate in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024)
Figure 50. Fapon Biotech Revenue Growth Rate in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024)
Figure 51. Labcorp Revenue Growth Rate in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
